Public Citizen’s Health Research Group

Off-label promotions of diabetes meds sometimes nonsensical, watchdog warns FDA


The nation's leading consumer watchdog is asking the Food and Drug Administration to prohibit direct-to-consumer diabetes drug advertising promoting unapproved off-label benefits like weight and blood pressure reduction.

Higher dose of Alzheimer's drug approved despite FDA warnings, report shows


Makers of the Alzheimer's drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.